NumFin

Abiomed, Inc.

Símbolo: ABMD

NASDAQ

381.02

USD

Precio de mercado actual

  • 126.8485

    Ratio PER

  • -5.7181

    Ratio PEG

  • 17.18B

    Capitalización MRK

  • 0.00%

    Rendimiento DIV

Abiomed, Inc. (ABMD) Estados Financieros

Download
AnualTrimestral
LinealLog
En el gráfico puede ver los números predeterminados en dinámica para Abiomed, Inc. (ABMD). Los ingresos de la empresa muestran la media de NaN M, que es NaN %. El beneficio bruto medio de todo el periodo es NaN M, que es NaN %. El coeficiente medio de beneficio bruto es NaN %. El crecimiento de los ingresos netos del último año de la empresa es NaN %, que es igual a NaN % % de media en toda la historia de la empresa.,

AnualTrimestral
10Y20Y30Y40Y

Balance de situación

Sumergiéndonos en la trayectoria fiscal de Abiomed, Inc., observamos un crecimiento medio de los activos. Esta tasa, curiosamente, se sitúa en , reflejando tanto los máximos como los mínimos de la empresa. Si se compara trimestre a trimestre, esta cifra se ajusta a . Una mirada retrospectiva al año pasado revela un cambio total de activos de NaN. El valor para los accionistas, representado por el total de fondos propios, se valora en NaN en la moneda de referencia. La variación interanual de este aspecto es del NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987

balance-sheet.row.cash-and-short-term-investments

3092.52758.6583.7443.1
491.7
362.2
229.9
212.1
132
76.6
76.7
77.2
60.3
58.3
57.2
38.3
75.1
30.8
41.5
27.3
54.4
71.3
92.5
106.4
18.2
26.4
9.4
10.6
0.6
0.5
0.7
4.7
8.1
24.6
10.4
13.3
2.4

balance-sheet.row.short-term-investments

2452.62625.8351250.8
370.7
319.3
190.9
163.8
109.6
55.7
67.3
71.2
54.5
53.5
55.4
36.3
5.5
23
33.9
20.4
9.9
25.7
2
4.5
8.9
23.7
7.7
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

365.1490.697.284.7
90.8
70
54.1
42.8
31.8
24.4
22.9
20.5
15.4
13.5
15.7
14.1
10.9
8.9
8.6
6
5.4
7.3
10
6.7
6.4
5.4
4.8
2.6
1.8
1.7
0.8
0.6
0.7
0.7
0.8
0.5
0.2

balance-sheet.row.inventory

381.799481.190.1
80.9
50.2
34.9
26.7
16.8
13.9
14.9
11.1
7.5
9.2
14.8
17.4
8.6
4.9
3.9
2.7
2.9
4.2
3.7
3.5
2.9
2.3
1.8
1.7
1.4
2.2
1.5
0.9
1.2
1.1
0.9
0.6
0.4

balance-sheet.row.other-current-assets

145.1933.32618
13.7
11.8
8
6.8
39.6
3.1
2
1.7
1.5
1.7
0.8
1.7
1.8
1.9
1.2
1
0.9
0.8
0.8
0.5
0.3
0.2
0.2
0.1
3.9
2.7
9
13.8
14
0.2
0.1
0
0.4

balance-sheet.row.total-current-assets

3984.64976.5788635.9
677.2
494.3
327
288.4
220.1
118
116.6
110.5
84.7
82.7
88.5
71.5
96.4
46.4
55.2
37
63.6
83.7
107
117.1
27.8
34.3
16.2
15
7.7
7.1
12
20
24
26.6
12.2
14.4
3.4

balance-sheet.row.property-plant-equipment-net

827.51212203.2176.7
145
117.2
87.8
23.2
9.1
6.9
6.5
6.4
6.3
6.8
7.8
7.6
5.8
4.8
2.8
3.2
4
4.7
4.8
4
3.9
3.7
1.9
0.6
0.5
0.6
0.7
0.6
1.1
1.1
0.3
0.3
0.3

balance-sheet.row.goodwill

302.0576.878.632
32.6
35.8
31
33
31.5
38
35.4
36.8
38.9
37.2
31.3
31.6
26.7
19.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

190.6345.647.522.6
15.2
16.7
14.5
15.4
14.7
0
0
0.1
1.6
3
4.4
6.9
7.3
8.2
0.9
0.8
0.7
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0.3
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

492.68122.412654.5
47.8
52.5
45.5
48.4
46.2
38
35.4
37
40.6
40.1
35.7
38.5
34
27.3
0.9
0.8
0.7
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0.3
0
0
0
0

balance-sheet.row.long-term-investments

1311.42351.9365.7302.2
21.7
37.5
47.1
1
14
41.8
11.4
0
0
0
3.7
0
0
0
2.1
18.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

50.2110.611.443.3
77.5
70.7
34.7
58.5
45.2
0
0
0
0
0
0
0
0
0.3
-2.1
-18.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0003.8
85.1
14.2
8.3
4.4
3.7
0.8
0
0
0
0
0.3
0.5
0
-0.3
2.1
18.2
0
1.1
6.3
0.7
1.3
0.6
0.5
0.6
6.5
7.6
9.5
5
4.5
0
0
0
0

balance-sheet.row.total-non-current-assets

2681.81696.9706.4580.6
377.1
292.1
223.5
135.5
118.2
87.4
53.4
43.4
46.9
46.9
47.5
46.5
39.8
32.1
5.8
22.2
4.8
5.8
11
4.6
5.1
4.3
2.4
1.2
7
8.3
10.4
5.8
5.9
1.1
0.3
0.3
0.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

6666.451673.41494.41216.5
1054.3
786.4
550.4
423.9
338.4
205.4
170
153.9
131.6
129.6
136
118
136.2
78.5
61.1
59.2
68.3
89.5
118
121.8
33
38.6
18.5
16.2
14.7
15.4
22.4
25.8
29.9
27.7
12.5
14.7
3.7

balance-sheet.row.account-payables

137.2835.334.832.8
32.2
23.6
20.6
9.4
10.4
7.7
7.7
6.9
6.3
3.8
5.5
9
5.2
3.1
1.1
1.4
1.1
2
2.1
1.6
0.9
2.1
1.3
0.8
0.2
0.4
0.5
0.4
0.3
0
0
0
0

balance-sheet.row.short-term-debt

66.6706675.1
12.3
4.6
0.8
2.5
1.5
1.4
2.1
0.9
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

20.021.95.921.6
12.3
4.6
3.2
2.5
1.5
1.4
2.1
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0000
0
0
15.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
-15.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

235.3176.73.84.9
45.2
41.6
37.7
25.9
20.4
16.5
13.1
11.5
14.1
13
10.8
9.3
7
5.2
3.6
3.3
4.2
5.6
5.6
6.4
4.8
2.9
2
1.5
1.2
0.7
0.7
0.8
0.6
1.3
1.2
1.2
1.4

balance-sheet.row.total-non-current-liabilities

114.1331.635.719.1
11.5
12.2
28.7
8.6
7.5
6.6
5.9
5.2
4.5
3.5
2.4
5
1.2
0.3
0
0
0
0
0.4
0.7
0.2
0.7
0
0
0
3.7
8.7
8.3
7.8
0
0
0
-0.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
16.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

654.2170.1164.7151
117.5
96.9
98.3
55.2
46.8
37.1
32.9
27.6
26.8
21.6
20
24.4
14.1
9
4.9
4.8
6.2
10.2
9.3
8.9
5.9
5.6
3.3
2.3
1.4
4.8
9.9
9.5
8.7
1.3
1.2
1.2
1.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

1.820.50.50.5
0.5
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

4012.96964.5828602.5
399.5
140.5
-47
-99.1
-137.2
-250.9
-258.3
-273.3
-274.8
-263
-244
-212.4
-171.2
-143.3
-113.9
-111.5
-102.1
-84.4
-53.1
-41.7
-31.2
-24.5
-22
-22.8
-23.2
-22.9
-20.9
-17
-11.9
-5.3
-3.4
-1.1
-0.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

-132.56-27.2-11.4-11.2
-14.7
-4.2
-20.6
-14.5
-17.3
-0.7
-3.7
-1.8
0.7
-1
-1.7
5
0.6
-2.1
-0.3
-0.1
-8.6
3.1
3.1
-5.4
-3.9
-2.7
-2.6
-2.3
-2.1
-1.9
-1.6
-1.4
-1.1
-0.8
-0.7
-0.5
-0.3

balance-sheet.row.other-total-stockholders-equity

2130.03565.5512.7473.7
551.7
552.8
519.2
482
445.7
419.6
398.7
400.9
378.4
371.6
361.3
300.7
292.4
214.6
170.1
165.7
172.5
160.4
158.4
159.9
62.1
60.2
39.8
39
38.6
35.4
35
34.7
34.2
32.5
15.4
15.1
3.3

balance-sheet.row.total-stockholders-equity

6012.251503.31329.71065.5
936.9
689.5
452.1
368.8
291.6
168.4
137.1
126.3
104.7
108
116
93.6
122.1
69.5
56.2
54.3
62.1
79.3
108.7
112.9
27.1
33
15.2
13.9
13.3
10.6
12.5
16.3
21.2
26.4
11.3
13.5
2.4

balance-sheet.row.total-liabilities-and-stockholders-equity

6666.451673.41494.41216.5
1054.3
786.4
550.4
423.9
338.4
205.4
170
153.9
131.6
129.6
136
118
136.2
78.5
61.1
59.2
68.3
89.5
118
121.8
33
38.6
18.5
16.2
14.7
15.4
22.4
25.8
29.9
27.7
12.5
14.7
3.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

6012.251503.31329.71065.5
936.9
689.5
452.1
368.8
291.6
168.4
137.1
126.3
104.7
108
116
93.6
122.1
69.5
56.2
54.3
62.1
79.3
108.7
112.9
27.1
33
15.2
13.9
13.3
10.6
12.5
16.3
21.2
26.4
11.3
13.5
2.4

balance-sheet.row.total-liabilities-and-total-equity

6666.45---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

3764.04977.7716.7553
392.4
356.8
238.1
164.8
123.6
97.4
78.7
71.2
54.5
53.5
59.1
36.3
5.5
23
36
38.6
9.9
25.7
2
4.5
8.9
23.7
7.7
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0000
0
0
16.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

-639.9-132.8-232.7-192.3
-121
-43
-22.7
-48.2
-22.4
-20.9
-9.5
-6
-5.8
-4.8
-1.8
-2
-69.6
-7.8
-7.6
-6.9
-44.6
-45.6
-90.2
-101.7
-9.3
-2.7
-1.6
-2.9
-0.6
-0.5
-0.7
-4.7
-8.1
-24.6
-10.4
-13.3
-2.4

Estado de tesorería

El panorama financiero de Abiomed, Inc. ha experimentado un cambio notable en el flujo de caja libre durante el último periodo, mostrando un cambio de NaN. La empresa ha ampliado recientemente su capital social mediante la emisión de NaN, marcando una diferencia de NaN con respecto al año anterior. Las actividades de inversión de la empresa dieron lugar a una utilización neta de efectivo, que ascendió a NaN en la moneda de referencia. Esto supone un cambio de NaN con respecto al año anterior. En el mismo período, la compañía registró NaN, NaN y NaN, que son importantes para comprender las estrategias de inversión y reembolso de la compañía. Las actividades de financiación de la empresa dieron lugar a un uso neto de efectivo de NaN, con una diferencia interanual de NaN. Además, la empresa destinó NaN al pago de dividendos a sus accionistas. Al mismo tiempo, realizó otras maniobras financieras, denominadas NaN, que también afectaron significativamente a su flujo de caja durante este periodo. El conjunto de estos componentes ofrece una imagen completa de la situación financiera de la empresa y de su enfoque estratégico de la gestión de la tesorería.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

cash-flows.row.net-income

266.76136.5225.5203
259
112.2
52.1
38.1
113.7
7.4
15
1.5
-11.8
-19
-31.6
-40.9
-27.9
-29.4
-2.3
-9.4
-18.2
-21.7
-11.4
-10.5
-6.7
-2.5
0.7
0.5
-0.4
-2
-3.9
-5.1
-6.6

cash-flows.row.depreciation-and-amortization

27.5628.124.120.4
14.1
11
6.2
3.3
2.8
2.5
2.7
4.3
3.9
4.9
5
6.1
3.9
2.7
1.2
1.4
1.7
1.8
3
1.7
1.4
0.9
0.4
0.3
0.4
0.3
0.3
0.6
0.3

cash-flows.row.deferred-income-tax

-13.22.429.433
-7.7
42.6
25.8
22.3
-87.1
0.9
0.8
0.8
1
1
0.7
0.5
0.5
0.3
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

53.7552.74739.8
54.5
40.4
32.9
29.1
16.5
11.2
9.5
7.8
5.4
5.4
8.8
5.4
5.8
0.4
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-23.26-30.2-17.48
-38.8
-18.9
5.3
-15.6
-4.7
-0.5
-2.8
-11.7
0.5
3.6
-3.5
-8
-2.5
2.8
-4.1
-2.1
-0.2
-0.4
-3.5
1.5
-2.1
0.9
-1.4
-0.3
1.1
-1.8
-0.8
0.9
-0.7

cash-flows.row.account-receivables

-8.515.3-12.15.6
-22
-15.3
-11.6
-10.9
-8
-1.3
-2.6
-5.3
-1.9
2.2
-2.5
-2.8
-1.9
0.3
-2.6
-0.6
1.5
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-36-29.32.5-13.2
-37.2
-15.7
-12.3
-11.5
-7
-0.6
-5.3
-6.2
-1.5
0.9
-1.6
-11.1
-4.1
-0.2
-1.2
0.2
1.4
-0.7
-0.1
-0.7
-0.6
-0.9
-0.2
-0.2
0.8
-0.7
-0.7
0.3
-0.1

cash-flows.row.account-payables

8.480.62.62.6
8
4.4
7.6
-2.6
3.4
-0.1
1.2
0.3
2.5
-1.4
-2.4
3.2
1.6
1.3
-0.2
0.3
-0.9
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

12.77-6.8-10.513.1
12.4
7.6
21.6
9.4
6.8
1.5
3.9
-0.5
1.4
1.8
3
2.6
2
1.4
-0.2
-2
-2.1
0.3
-3.4
2.1
-1.5
1.8
-1.2
0
0.3
-1.1
-0.1
0.6
-0.6

cash-flows.row.other-non-cash-items

-60.6395.8-3410.7
-28.8
5.3
-7.2
-0.4
2.1
2.1
1.2
1
2.5
-3.1
2.2
8.1
0.3
13.9
0.1
0
0.5
0.3
0
0
0
0
0
0
-0.2
0.1
0.1
0.2
3

cash-flows.row.net-cash-provided-by-operating-activities

250.98000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-33.76-35.8-53.4-44
-44
-55.9
-50.4
-15.6
-5.2
-2.8
-2.8
-1.7
-1.8
-1.8
-3.8
-3.8
-2.4
-3.1
-0.7
-0.4
-0.8
-1.6
-2.6
-1.4
-1.6
-16
-1.6
-0.3
-0.1
-0.2
-0.3
-0.1
-0.2

cash-flows.row.acquisitions-net

0-82.8-52.20
0
0
0
0
-15.7
0
0
1.7
3.8
4.6
5.6
0
0
-2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-745.81-805.9-582.3-632.2
-404.3
-331.8
-281.4
-261.7
-100.5
-87.8
-49.4
-24.5
-8
-11.9
-60.2
-66.4
-17.7
-29
-39.5
-39
-14.6
-38
-27
-8.3
-25.5
0
0
0
-1.3
-2.9
-4.3
0
0

cash-flows.row.sales-maturities-of-investments

616.66543.5464.5550.8
331.9
206.9
205.5
219.6
71.5
68.3
42
8.8
7
17.8
37.1
34.5
35.2
42
42.2
10.2
30.4
14.4
29.4
12.7
40.4
0
0
2.7
0
6.2
4.9
0
5.5

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
-1.7
-3.4
0
-5.6
-5.1
0
0
0
0
-0.1
0
0
0
0
-2.5
0
-0.8
0.7
0
0.1
0
-0.1

cash-flows.row.net-cash-used-for-investing-activites

-162.91-381-223.3-125.5
-116.5
-180.8
-126.3
-57.7
-49.9
-22.3
-10.3
-17.5
-2.4
8.8
-26.8
-40.9
15.1
7.4
1.9
-29.2
14.8
-25.2
-0.1
3.1
13.3
-18.5
-1.6
1.6
-0.7
3.1
0.4
-0.1
5.2

cash-flows.row.debt-repayment

0000
0
-0.5
-0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

10.357.25.55.1
3.1
2.4
1.7
1.1
0.8
-0.3
-0.3
0.4
0.3
0.3
42.2
3.9
66.6
2.2
4.1
1.6
0.3
1
0.9
96.3
0.8
20.3
0.5
0.1
0
0.1
0.1
0.1
1.4

cash-flows.row.common-stock-repurchased

-126.620-11.3-84.9
0
0
0
0
0
-0.4
-15.3
0
0
0
0
-1.9
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-19.26-9.4-2.2-37.9
-58.8
-11
2.6
6
8.7
10.3
3.7
14.3
1.1
0.6
4
0
0
0
0
0
-0.1
-0.5
-0.2
0.6
0
0
0
0
0
0
-0.1
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

-135.53-2.2-8.1-117.7
-55.8
-9.1
3.9
7.2
9.5
9.6
-11.8
14.7
1.4
1
46.2
2.1
66.6
2.1
4.1
1.6
0.3
0.5
0.6
96.9
0.8
20.3
0.5
0.1
0
0.1
0
0.1
1.4

cash-flows.row.effect-of-forex-changes-on-cash

-12.08-2.1-2.8-0.4
-1.9
1.3
-1.8
-0.4
-1.5
0.6
-0.9
-0.7
0.4
0.6
-1.4
0.1
0
0.1
-0.1
0.1
0
0
0
0
0
0
0
0
0
0.3
0
3.5
-1.2

cash-flows.row.net-change-in-cash

-59.55-99.940.471.3
78
3.9
-9.2
25.8
1.5
11.5
3.5
0.2
1
3
-0.3
-67.6
61.8
0.2
0.8
-37.7
-1.1
-44.8
-11.5
92.6
6.6
1.1
-1.3
2.3
0.2
0.1
-3.9
0.1
1.4

cash-flows.row.cash-at-end-of-period

639.9132.8232.7192.3
121
43
39
48.2
22.4
20.9
9.5
6
5.8
4.8
1.8
2
69.6
7.8
7.6
6.9
44.6
45.7
90.5
101.9
9.3
2.7
1.6
2.9
0.7
0.8
0.8
8.1
6.8

cash-flows.row.cash-at-beginning-of-period

699.45232.7192.3121
43
39
48.2
22.4
20.9
9.5
6
5.8
4.8
1.8
2
69.6
7.8
7.6
6.8
44.6
45.7
90.5
101.9
9.3
2.7
1.6
2.9
0.6
0.5
0.7
4.7
8
5.4

cash-flows.row.operating-cash-flow

250.98285.4274.6314.9
252.2
192.5
115.1
76.8
43.3
23.5
26.4
3.6
1.6
-7.4
-18.3
-28.9
-19.8
-9.3
-5.2
-10.1
-16.2
-20.1
-12
-7.3
-7.4
-0.7
-0.2
0.6
0.9
-3.4
-4.3
-3.4
-4

cash-flows.row.capital-expenditure

-33.76-35.8-53.4-44
-44
-55.9
-50.4
-15.6
-5.2
-2.8
-2.8
-1.7
-1.8
-1.8
-3.8
-3.8
-2.4
-3.1
-0.7
-0.4
-0.8
-1.6
-2.6
-1.4
-1.6
-16
-1.6
-0.3
-0.1
-0.2
-0.3
-0.1
-0.2

cash-flows.row.free-cash-flow

217.22249.6221.2270.9
208.2
136.7
64.7
61.2
38.1
20.7
23.6
1.9
-0.2
-9.2
-22.1
-32.7
-22.2
-12.4
-5.9
-10.6
-17
-21.7
-14.5
-8.7
-9
-16.7
-1.8
0.2
0.8
-3.6
-4.6
-3.5
-4.2

Fila de la Cuenta de Resultados

Los ingresos de Abiomed, Inc. experimentaron una variación del NaN% con respecto al periodo anterior. El beneficio bruto de ABMD es de NaN. Los gastos de explotación de la empresa son de NaN, con una variación del NaN% respecto al año anterior. Los gastos por depreciación y amortización ascienden a NaN, lo que supone una variación del NaN% con respecto al último periodo contable. Los gastos de explotación ascienden a NaN, con una variación interanual del NaN%. Los gastos de venta y marketing ascienden a NaN, lo que supone una variación interanual del NaN%. El EBITDA basado en las cifras recientes es de NaN, lo que representa un crecimiento interanual del NaN%. El resultado de explotación es NaN, que muestra una variación del NaN% con respecto al año anterior. La variación de los ingresos netos es del NaN%. Los ingresos netos del último año fueron de NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987

income-statement-row.row.total-revenue

1074.11031.8847.5840.9
769.4
593.7
445.3
329.5
230.3
183.6
158.1
126.4
101.2
85.7
73.2
58.9
50.6
43.7
38.2
25.7
23.3
26.9
24.9
22.5
22.1
22.4
16.5
12.8
9.2
6.7
3.4
2.7
2
3
2.9
4.2
4.7

income-statement-row.row.cost-of-revenue

200.59188.2161.9151.3
129.6
98.6
70.6
50.4
39.9
37.3
31.6
24.5
22
22.5
20.4
15.1
12
11.7
9.4
7.6
7.5
7.9
7.4
5.9
6.8
6.5
5.4
3.9
2.9
1.9
3
2
1.3
1
1.1
0.2
3.7

income-statement-row.row.gross-profit

873.51843.6685.6689.6
639.9
495.2
374.7
279.1
190.4
146.3
126.5
101.9
79.2
63.2
52.8
43.9
38.6
32
28.9
18.1
15.8
18.9
17.5
16.6
15.3
15.9
11.1
8.9
6.3
4.8
0.4
0.7
0.7
2
1.8
4
1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

167.22---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-7.58051.9-4.6
30.4
-0.4
-0.3
0.3
-0.1
0
0.3
1.5
1.4
1.5
1.6
2.8
1.6
1.3
13.2
13.6
20.4
0
0
0
0
-1.2
0
0
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.operating-expenses

619.4586.9456.1440.4
415.1
338
284.5
214
161.7
138
110
100.3
90.4
88.3
82.3
80.4
66.3
62.3
32.1
28.4
35.3
43.6
35.1
28.2
23.2
16.9
10.9
9
7.2
7.1
4.9
7
9.1
5.4
5
5.3
1.1

income-statement-row.row.cost-and-expenses

819.99775618591.7
544.6
436.6
355.2
264.4
201.6
175.3
141.6
124.9
112.3
110.8
102.7
95.4
78.4
74
41.5
36
42.8
51.5
42.5
34.1
30
23.4
16.3
12.9
10.1
9
7.9
9
10.4
6.4
6.1
5.5
4.8

income-statement-row.row.interest-income

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

87.06-182.158.77.6
38.5
3.3
1.2
0.7
0.1
0.2
0.3
1
0.3
6.7
-1.3
-5.1
0.3
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0.4
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-7.58051.9-4.6
30.4
-0.4
-0.3
0.3
-0.1
0
0.3
1.5
1.4
1.5
1.6
2.8
1.6
1.3
13.2
13.6
20.4
0
0
0
0
-1.2
0
0
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.total-operating-expenses

87.06-182.158.77.6
38.5
3.3
1.2
0.7
0.1
0.2
0.3
1
0.3
6.7
-1.3
-5.1
0.3
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0.4
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.interest-expense

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

30.4828.117.48.3
14.1
11
6.2
3.3
2.8
2.5
2.7
4.3
3.9
4.9
5
6.1
3.9
2.7
1.2
1.4
1.7
1.8
3
1.7
1.4
0.9
0.4
0.3
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.ebitda-caps

284.19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

253.61372.7229.6249.2
224.8
157.1
90.1
65.1
28.7
8.4
16.5
1.5
-11.2
-25.1
-29.5
-36.5
-28.5
-30.3
-3.3
-10.3
-19.5
-24.6
-17.6
-11.6
-7.9
-1
0.2
0
-0.9
-2.3
-4.5
-6.3
-8.4
-3.4
-3.2
-1.3
-0.1

income-statement-row.row.income-before-tax

341.16190.6288.2256.8
263.4
160.4
91.3
65.8
28.8
8.5
16.9
2.5
-10.9
-18.4
-30.8
-40.4
-27.4
-29.1
-2.3
-9.4
-18.2
0
0
0
0
0
0
0
-0.5
-1.9
-3.9
-5.1
-6.7
-1.9
-2.3
-0.6
0.1

income-statement-row.row.income-tax-expense

74.454.162.753.8
4.3
48.3
39.2
27.7
-84.9
1.2
1.8
1
0.9
0.7
0.8
0.5
0.5
0.4
0.1
0.2
0.2
-2.9
-6.2
-1.1
-1.2
1.5
-0.5
-0.5
-0.5
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.net-income

266.76136.5225.5203
259
112.2
52.1
38.1
113.7
7.4
15
1.5
-11.8
-19
-31.6
-40.9
-27.9
-29.4
-2.3
-9.4
-18.2
-21.7
-11.4
-10.5
-6.7
-2.5
0.7
0.5
-0.4
-2
-3.9
-5.1
-6.6
-1.9
-2.2
-0.6
0.1
Acciones similares
También le puede interesar:
EAR
Eargo, Inc..
2.58 USD
NASDAQ
ELEAF
EL.En. S.p.A..
9.8 USD
PNK
FORZ
Forza Innovations Inc..
0.0001 USD
PNK
SILK
Silk Road Medical, Inc.
18.97 USD
NASDAQ
UNIVPHOTO.NS
Universus Photo Imagings Limited.
391 INR
NSE
SGMD.V
Salona Global Medical Device Corporation.
0.22 CAD
TSX
HTL.V
Hamilton Thorne Ltd..
1.45 CAD
TSX

Preguntas frecuentes

Cuánto es Abiomed, Inc. (ABMD) activos totales?

Abiomed, Inc. (ABMD) los activos totales son 1673393000.000.

¿Cuáles son los ingresos anuales de la empresa?

Los ingresos anuales son 543070000.000.

¿Cuál es el margen de beneficios de la empresa?

El margen de beneficios de la empresa es 0.818.

¿Qué es el flujo de caja libre de la empresa?

El flujo de caja libre es 5.493.

¿Cuál es el margen de beneficio neto de la empresa?

El margen de beneficio neto es 0.132.

¿Cuáles son los ingresos totales de la empresa?

Los ingresos totales son 0.361.

¿Qué es Abiomed, Inc. (ABMD) beneficio neto (ingresos netos)?

El beneficio neto (ingresos netos) es 136505000.000.

¿Cuál es la deuda total de la empresa?

La deuda total es 0.000.

¿Cuál es la cifra de gastos de explotación?

Los gastos de explotación son 586889000.000.

¿Cuál es la cifra de tesorería de la empresa?

La tesorería de la empresa es 182335000.000.